Global Nuclear Medicine/Radiopharmaceuticals Market was valued at USD 6.5 billion in 2019 which is expected to reach USD 12.25 billion by 2027 at a CAGR 9.88%.
Nuclear medicines/radiopharmaceuticals are radioactive compounds which are administered to patients and monitored via special imaging devices. These are used to diagnosis and therapeutic purposes. Nuclear medicines or radiopharmaceutical components are composed of organic molecules with radioisotopes. Radioisotopes emits gamma rays are used for diagnosis.
Get Free Sample Copy Of This Report @ https://qualiketresearch.com/request-sample/Nuclear-MedicineRadiopharmaceuticals-Market/request-sample
Increase in incidences of chronic diseases like cancer is the key driving factor which is expected to boost the global nuclear medicine/ radiopharmaceuticals market growth. For instance, in 2018, according to World Health Organization (WHO) around 9.6 million people were dead due to cancer across the world. Also, increase in prevalence of cardiovascular diseases will have the positive impact on global nuclear medicine/ radiopharmaceuticals market growth. Furthermore, increase in technological advancements is expected to propel the global nuclear medicine/ radiopharmaceuticals market growth.
Several key operating players are listed in this report to provide readers with a comprehensive overview of the competitive landscape in the Nuclear Medicine/Radiopharmaceuticals market. The major strategies used by these players are discussed in the report to provide readers with an idea of what works & what doesn’t, in the Nuclear Medicine/Radiopharmaceuticals market. Individual players are analysed in detail in the report in order to elaborate on their regional presence & product catalogue, providing a clear image of each major player operating in the global Nuclear Medicine/Radiopharmaceuticals market.
Inquire To Know More About This Report @ https://qualiketresearch.com/request-sample/Nuclear-MedicineRadiopharmaceuticals-Market/inquire-before-buying
Global Nuclear Medicine/Radiopharmaceuticals Market is segmented into type such as Diagnostic Nuclear Medicine (SPECT Radiopharmaceuticals, Tc-99m, Tl-201, Ga-67, and Others), PET Radiopharmaceuticals (F-18, Rubidium-82, and Others), by procedure such as Brachytherapy Isotopes, Alpha Emitters, Beta Emitters, Therapeutic Procedures, PET Radiopharmaceuticals, and SPECT Radiopharmaceuticals. Further, Global Nuclear Medicine/Radiopharmaceuticals Market is segmented into application such as Cardiology, Oncology, Neurology, Thyroid, and Others.
Also, Global Nuclear Medicine/Radiopharmaceuticals Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Market key Players
Various key players are discussed in this report such as Iba Molecular, Advanced Accelerator Applications S.A., Nordion, Inc, Eczacibasi-Monrol Nuclear Products, Bracco Imaging S.P.A, Bayer AG, Lantheus Medical Imaging, Inc., GE Healthcare, Mallinckrodt PLC, and Cardinal Health, Inc.
Get Discount On This Report @ https://qualiketresearch.com/request-sample/Nuclear-MedicineRadiopharmaceuticals-Market/ask-for-discount
Market Taxonomy
By Type
By Procedure
By Application
By Region
Click here to get the short-term and long-term impact of COVID-19 on this Market.
https://qualiketresearch.com/reports-details/Nuclear-MedicineRadiopharmaceuticals-Market